These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7560740)
1. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration. Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740 [TBL] [Abstract][Full Text] [Related]
2. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats. Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886 [TBL] [Abstract][Full Text] [Related]
3. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats. Kostial K; Blanusa M; Simonović I; Jones MM; Singh PK J Appl Toxicol; 1993; 13(5):321-5. PubMed ID: 8258628 [TBL] [Abstract][Full Text] [Related]
4. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats. Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123 [TBL] [Abstract][Full Text] [Related]
5. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats. Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694 [TBL] [Abstract][Full Text] [Related]
6. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats. Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK J Appl Toxicol; 1997; 17(1):71-4. PubMed ID: 9048230 [TBL] [Abstract][Full Text] [Related]
7. Dose-related efficiency of mono-n-hexyl meso-2,3-dimercaptosuccinate in decreasing 203Hg retention in rats. Kostial K; Blanusa M; Prester L; Jones MM; Singh PK Pharmacol Toxicol; 1995 Jul; 77(1):79-80. PubMed ID: 8532616 [No Abstract] [Full Text] [Related]
8. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats. Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262 [TBL] [Abstract][Full Text] [Related]
9. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice. Gale GR; Smith AB; Jones MM; Singh PK Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277 [TBL] [Abstract][Full Text] [Related]
10. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats. Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats. Flora SJ; Mehta A; Rao PV; Kannan GM; Bhaskar AS; Dube SN; Pant BP Toxicology; 2004 Feb; 195(2-3):127-46. PubMed ID: 14751669 [TBL] [Abstract][Full Text] [Related]
12. Mobilization of lead in mice by administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid. Walker EM; Stone A; Milligan LB; Gale GR; Atkins LM; Smith AB; Jones MM; Singh PK; Basinger MA Toxicology; 1992 Nov; 76(1):79-87. PubMed ID: 1335621 [TBL] [Abstract][Full Text] [Related]
13. Design of in vivo cadmium-mobilizing agents: synthesis and properties of monobenzyl meso-2,3-dimercaptosuccinate. Jones MM; Singh PK; Basinger MA; Gale GR; Smith AB; Harris WR Chem Res Toxicol; 1994; 7(3):367-73. PubMed ID: 8075368 [TBL] [Abstract][Full Text] [Related]
14. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats. Bhadauria S; Flora SJ Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449 [TBL] [Abstract][Full Text] [Related]
15. Cadmium mobilization in vivo by intraperitoneal or oral administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid in the mouse. Jones MM; Singh PK; Gale GR; Smith AB; Atkins LM Pharmacol Toxicol; 1992 May; 70(5 Pt 1):336-43. PubMed ID: 1319053 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice. Bellés M; Sánchez DJ; Gómez M; Domingo JL; Jones MM; Singh PK Toxicology; 1996 Jan; 106(1-3):93-7. PubMed ID: 8571406 [TBL] [Abstract][Full Text] [Related]
17. Effect of chelators, monoisoamyl meso-2,3-dimercaptosuccinate and N-(4-methylbenzyl)-4-O-(beta-D-galactopyranosyl)-D-glucamine-N-carbodit hioate, on cadmium and essential element levels in mice. Eybl V; Kotyzová D; Koutenský J; Jones MM; Singh PK Analyst; 1995 Mar; 120(3):855-7. PubMed ID: 7741241 [TBL] [Abstract][Full Text] [Related]
18. Haematological, hepatic and renal alterations after repeated oral or intraperitoneal administration of monoisoamyl DMSA. I. Changes in male rats. Mehta A; Kannan GM; Dube SN; Pant BP; Pant SC; Flora SJ J Appl Toxicol; 2002; 22(6):359-69. PubMed ID: 12424740 [TBL] [Abstract][Full Text] [Related]
19. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice]. Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787 [TBL] [Abstract][Full Text] [Related]
20. Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice. Kreppel H; Reichl FX; Kleine A; Szinicz L; Singh PK; Jones MM Fundam Appl Toxicol; 1995 Jul; 26(2):239-45. PubMed ID: 7589912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]